Multicenter studies of ultra-high-dose, short-duration streptokinase treatment of deep vein thrombosis
- 30 April 1996
- journal article
- Published by Elsevier in Current Therapeutic Research
- Vol. 57 (4) , 251-267
- https://doi.org/10.1016/s0011-393x(96)80033-6
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Recombinant tissue-type plasminogen activator versus a novel dosing regimen of urokinase in acute pulmonary embolism: a randomized controlled multicenter trialJournal of the American College of Cardiology, 1992
- Fibrinolytic therapy for venous thrombosisProgress in Cardiovascular Diseases, 1991
- Short-Term Ultrahigh Streptokinase Treatment of Chronic Arterial Occlusions and Acute Deep Vein ThrombosesSeminars in Thrombosis and Hemostasis, 1991
- Fatal pulmonary embolism caused by streptokinase treatment of deep venous thrombosis of the leg?Journal of Internal Medicine, 1990
- Streptokinase therapy for deep vein thrombosis: A comprehensive review of the english literatureThe American Journal of Medicine, 1990
- Hemorrhagic Complications of Long-term Anticoagulant TherapyChest, 1989
- Hazards of thrombolytic therapy in deep vein thrombosisBritish Journal of Surgery, 1987
- Fibrinolytische Behandlung tiefer Venenthrombosen mit Streptokinase in ultrahoher DosierungDeutsche Medizinische Wochenschrift (1946), 1987
- Thrombolytic Therapy in Thrombosis: A National Institutes of Health Consensus Development ConferenceAnnals of Internal Medicine, 1980
- Venous Thromboembolism and Other Venous Disease in the Tecumseh Community Health StudyCirculation, 1973